Seqirus’ Influenza Vaccine Manufacturing Facility, Melbourne
Seqirus, an influenza vaccine maker, is building a new cell-based influenza vaccine manufacturing facility in...
Mesoblast signs ARDS therapy development deal with Novartis
Mesoblast and Novartis have signed an exclusive agreement for the development, manufacture and commercialisation of...
Breast cancer breakthrough: could a new therapy silence stubborn TNBC?
Despite significant advances in breast cancer treatments over the last half century, one subtype of...
Australia to acquire 40 million doses of Novavax Covid-19 vaccine
Novavax has signed a non-binding Heads of Terms document with the Australian government to supply...
Ena Respiratory’s nasal spray shows promise against Covid-19
Australian biotech company Ena Respiratory has said that its nasal spray has significantly mitigated Covid-19...
Australia enters $1.2bn Covid-19 vaccine supply agreement
The Government of Australia has signed a supply and production agreement valued at A$1.7bn ($1.2bn)...
UQ’s Covid-19 vaccine shows effectiveness in preclinical studies
The University of Queensland (UQ) in Australia has reported positive data from preclinical tests of...
Australia signs deal for AstraZeneca’s Covid-19 vaccine
The Australian Government has signed an agreement with AstraZeneca for the supply of the company’s...
Recce Pharma: a new frontier in the fight against AMR
Antimicrobial resistance is a looming threat for modern medicine, but Australian biotech Recce Pharmaceuticals might...